Company Search:
Advanced Search
Sponsored Links
Argos Therapeutics Inc Company Snapshot
Argos Therapeutics Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Argos Therapeutics Inc with three other companies in this sector in the United States: Syndax Pharmaceuticals Inc (2017 sales of $2.11 million of which 100% was Pharmaceutical), Innovate Biopharmaceuticals Inc ($1.88 million ), and Alpine Immune Sciences Inc ($1.73 million ).

Sales Analysis. During the year ended December of 2017, sales at Argos Therapeutics Inc were $1.90 million. This is an increase of 100.9% versus 2016, when the company's sales were $945,468.00 .
  Stock Performance Chart for Argos Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (9/19/2019): .05
(Figures in U.S. Dollars)
1 Week -7.5%   13 Weeks -15.0%  
4 Weeks -23.5%   52 Weeks -46.5%  
Argos Therapeutics Inc Key Data:
  Ticker: ARGSQ Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 1,899,398
(Year Ending Jan 2018).
Employees: 92
  Currency: U.S. Dollars Market Cap: N/A
  Fiscal Yr Ends: December Shares Outstanding: N/A
  Share Type: Common Closely Held Shares: N/A
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.